Standard lipid-lowering therapies in solid organ transplantations pose challenges Plates due to interactions with immunosuppressants.Proprotein convertase subtilisin/kexin type 9 inhibitors (PCSK9i) represent a new class of lipid-lowering therapies with potential promise in this population.We describe PCSK9i as an efficacious and 3 Piece Kitchen Island Set safe option for management of hypercholesterolemia in solid organ transplantations.
(Level of Difficulty: Advanced.).